GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » ROE % Adjusted to Book Value

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) ROE % Adjusted to Book Value : 0.00% (As of Apr. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics ROE % Adjusted to Book Value?

Advanced Proteome Therapeutics's ROE % for the quarter that ended in Apr. 2023 was -3,519.05%. Advanced Proteome Therapeutics's PB Ratio for the quarter that ended in Apr. 2023 was N/A. Advanced Proteome Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2023 was N/A.


Advanced Proteome Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Advanced Proteome Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics ROE % Adjusted to Book Value Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.05 -15.84 -10.39 - 59.95

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -321.69 -10.27 -17.13 -23.90 -

Competitive Comparison of Advanced Proteome Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Advanced Proteome Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Proteome Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's ROE % Adjusted to Book Value falls into.



Advanced Proteome Therapeutics ROE % Adjusted to Book Value Calculation

Advanced Proteome Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=198.43% / 3.31
=59.95%

Advanced Proteome Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-3,519.05% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Proteome Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Traded in Other Exchanges
Address
8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines